Chemicals CFO Front-Runs His Own Cross at $45.52

ISB Research · Favorable · sent to Ultimate members August 17, 2026

Kyrish Chuck runs the money at Celanese, and this $104,698 buy is the third insider check on the name in the past month. Here's what makes the timing interesting: price is back above the 8-day and the 8 is closing on the 20 from below. If it crosses, the systematic buyers show up, and the CFO is already positioned. The catch is the track record. Insiders on this name have been right roughly half the time at 30 days and worse at 90, so the cluster gives you a reason to watch, not a reason to back up the truck.

Ultimate members received this analysis in real time.